Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes

Journal of Clinical Investigation

Volumn 108, Issue 1, 2001, Pages 15-23

  Tilley, S L ^a   Coffman, T M ^a   Koller, B H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; PROSTAGLANDIN DERIVATIVE; PROSTANOID RECEPTOR; THROMBOXANE DERIVATIVE;

ENZYME ANALYSIS; GENE DISRUPTION; HUMAN; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACIDS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEVER; GTP-BINDING PROTEINS; HUMANS; IMMUNITY; INFLAMMATION; INFLAMMATION MEDIATORS; ISOENZYMES; MEMBRANE LIPIDS; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; PAIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THROMBOXANES;

EID: 0034943516     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200113416     Document Type: Review

References (49)

1. Inducible cyclooxygenase may have anti-inflammatory properties
2. Prostaglandin endoperoxide H synthase-1 and -2
3. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation
4. Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells
5. Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of pre stanoid biosynthesis in rat peritoneal macrophages
6. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
7. 2 production in human monocytes: Implications for the use of cyclooxygenase inhibitors
8. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2
9. Distribution and function of prostanoid receptors: Studies from knockout mice
10. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist
11. Salt-sensitive hypertension and reduced fertility in n rice lacking the prostaglandin EP2 receptor
12. 2 receptor
13. 4 triggers remodeling of the cardiovascular system at birth
14. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis
15. Thromboxane A2 receptor blocking abrogates donor specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides
16. 2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts
17. Distinct roles of prostaglandin H synthases 1 and 2 in T- cell development
18. 2 acts at two distinct pathways oft lymphocyte activation: Inhibition of interleukin 2 production and down-regulation of transferrin receptor expression
19. 2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins
20. 2
21. Thromboxane augmentation of altoreactive T cell function
22. 2 as a modulator of lymphocyte mediated inflammatory and humoral responses
23. 2
24. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
25. Genetic and pharmacological analysis of prostanoid receptor function
26. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
27. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
28. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase
29. 2 inhibits multiple steps in the NF-κB signaling pathway
30. Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis
31. Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin
32. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
33. 2
34. 2: Apparent correlation with in vivo modulation of mediator release
35. 2α on the immunologic release of mediators of inflammation from actively sensitized guinea-pig lung
36. In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs
37. 1 receptor mediates pain perception and regulates blood pressure
38. -/- mice
39. 3
40. 2 down-regulates the expression of HLA-DR antigen in human colon adenocarcinoma cell lines
41. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis
42. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
43. Allergic tung responses are increased in prostaglandin H synthase-deficient mice
44. Cyclooxygenase inhibition increases interleukin S and interleukin 13 production and airway hyperresponsiveness in allergic mice
45. 2 as a mediator of allergic asthma
46. Prostaglandin synthase I gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
47. Prostaglandin synthase 2 gene disruption causes severe renal pathology, in the mouse
48. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
49. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity